M 508 Acyclovir |
|
| (Acycloguanosine) | |
|
|
|
| Solid | 1 mg $215 |
| 5 mg $565 | |
| Screw cap v-vial | |
M.W. 225.20  | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 1386 Acyclovir, [8-14C]- Click here for Typical Certificate of Analysis |
|
| (Acycloguanosine, [8-14C]-) | |
| MORpure™ HPLC purified, Delivered ≥ 98% pure with dated HPLC radiochromatogram | |
| Ethanol:water (1:1) solution, 100 µCi/ml | 10 µCi (370 kBq) $1240 |
| > 50 mCi(1.85 GBq)/mmol | 25 µCi (925 kBq) $1660 |
| NextGen V-Vial - shipped on dry ice | |
M.W. 225.20  | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 995 Acyclovir, [side chain-2-3H]- Click here for Typical Certificate of Analysis |
|
| (Acycloguanosine, [side chain-2-3H]-) | |
|
|
|
| Ethanol:water (3:7) solution, 1 mCi/ml | |
| > 15 Ci(555 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
|
M.W. 225.20  | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 1506 Acyclovir, [2',8-3H]- |
|
| (Acycloguanosine, [2',8-3H]-) | |
|
|
|
| Ethanol:water (1:1) solution, 1 mCi/ml | Please Inquire for Pricing |
| > 40 Ci(1.48 TBq)/mmol | |
| NextGen V-Vial - shipped on dry ice | |
|
M.W. 225.20  | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 508 Acyclovir, [8-3H]- Click here for Typical Certificate of Analysis |
|
| (Acycloguanosine, [8-3H]-) | |
|
|
|
| Ethanol:water (1:1) solution, 1 mCi/ml | |
| > 15 Ci(0.555 TBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
|
M.W. 225.20  | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
M 652 Acyclovir monophosphate, diammonium salt Click here for Typical Certificate of Analysis |
|
| (ACV-MP) | |
|
|
|
| Solid | 1.5 µmol $355 |
| Screw cap v-vial - shipped on dry ice | 3 µmol $495 |
| 15 µmol $1190 | |
|
M.W. 305.2 for free acid  | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 652 Acyclovir monophosphate, diammonium salt, [8-3H]- Click here for Typical Certificate of Analysis |
|
| (ACV-MP, [8-3H]-) | |
|
|
|
| Ethanol:water (1:1) solution, 1 mCi/ml | |
| > 10 Ci(0.37 TBq)/mmol | 50 μCi (1.85 MBq) $1160 |
| NextGen V-Vial - shipped on dry ice | 250 μCi (9.25 MBq) $1970 |
|
M.W. 305.2 for free acid  | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
M 1583 Acyclovir triphosphate, tetraammonium salt Click here for Typical Certificate of Analysis |
|
| (ACV-TP, tetraammonium salt) | |
|
|
|
| Solid | 1 µmol $1185 |
| Screw cap v-vial - shipped on dry ice | 6 µmol $3440 |
|
M.W. 533.27  | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 1583 Acyclovir triphosphate, tetratriethylammonium salt, [8-3H]- |
|
| (ACV-TP, [8-3H]-) | |
|
|
|
| Ethanol:water (1:1) solution, 1 mCi/ml | |
| > 1 Ci(37 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
M.W. 465.14 for free acid  | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
